What is RXO Inc's earnings per share (EPS)?

RXO Inc (RXO) reported diluted earnings per share of $-0.59 for fiscal year 2025. This represents a 72.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

RXO Inc Financials

RXO

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows RXO Inc (RXO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 40/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

RXO Inc has an operating margin of -1.4%, meaning the company retains $-1 of operating profit per $100 of revenue. This below-average margin results in a low score of 19/100, suggesting thin profitability after operating expenses. This is down from -1.2% the prior year.

Growth

RXO Inc's revenue surged 26.2% year-over-year to $5.7B, reflecting rapid business expansion. This strong growth earns a score of 77/100.

Leverage

RXO Inc carries a low D/E ratio of 0.25, meaning only $0.25 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 97/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

RXO Inc's current ratio of 1.27 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 21/100, which could limit financial flexibility.

Cash Flow

While RXO Inc generated $51.0M in operating cash flow, capex of $59.0M consumed most of it, leaving -$8.0M in free cash flow. This results in a low score of 25/100, reflecting heavy capital investment rather than weak cash generation.

Returns

RXO Inc generates a -6.5% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from -18.0% the prior year.

Piotroski F-Score Neutral

5/9

RXO Inc passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed

-0.51x

For every $1 of reported earnings, RXO Inc generates $-0.51 in operating cash flow ($51.0M OCF vs -$100.0M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$5.7B

YoY+26.2%

5Y CAGR+11.3%

RXO Inc generated $5.7B in revenue in fiscal year 2025. This represents an increase of 26.2% from the prior year.

EBITDA

$37.0M

YoY+19.4%

5Y CAGR-22.9%

RXO Inc's EBITDA was $37.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 19.4% from the prior year.

Net Income

-$100.0M

YoY+65.5%

RXO Inc reported -$100.0M in net income in fiscal year 2025. This represents an increase of 65.5% from the prior year.

EPS (Diluted)

$-0.59

YoY+72.8%

RXO Inc earned $-0.59 per diluted share (EPS) in fiscal year 2025. This represents an increase of 72.8% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$8.0M

YoY+86.0%

RXO Inc generated -$8.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 86.0% from the prior year.

Cash & Debt

$17.0M

YoY-51.4%

5Y CAGR-24.7%

RXO Inc held $17.0M in cash against $387.0M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

164M

YoY+1.0%

RXO Inc had 164M shares outstanding in fiscal year 2025. This represents an increase of 1.0% from the prior year.

Margins & Returns

Gross Margin

19.7%

YoY-1.9pp

5Y CAGR-3.8pp

RXO Inc's gross margin was 19.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.9 percentage points from the prior year.

Operating Margin

-1.4%

YoY-0.1pp

5Y CAGR-3.2pp

RXO Inc's operating margin was -1.4% in fiscal year 2025, reflecting core business profitability. This is down 0.1 percentage points from the prior year.

Net Margin

-1.7%

YoY+4.6pp

5Y CAGR-3.0pp

RXO Inc's net profit margin was -1.7% in fiscal year 2025, showing the share of revenue converted to profit. This is up 4.6 percentage points from the prior year.

Return on Equity

-6.5%

YoY+11.5pp

5Y CAGR-10.5pp

RXO Inc's ROE was -6.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 11.5 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

RXO Inc spent $0 on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

$59.0M

YoY+31.1%

5Y CAGR+4.7%

RXO Inc invested $59.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 31.1% from the prior year.

RXO Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$5.7B+26.2%	$4.5B+15.9%	$3.9B-18.1%	$4.8B+2.3%	$4.7B+39.7%	$3.4B
Cost of Revenue	$4.6B+29.3%	$3.6B+20.2%	$3.0B-18.1%	$3.6B-1.5%	$3.7B+43.3%	$2.6B
Gross Profit	$1.1B+14.8%	$985.0M+2.6%	$960.0M-18.1%	$1.2B+16.3%	$1.0B+27.8%	$789.0M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$832.0M+24.9%	$666.0M+12.7%	$591.0M-7.7%	$640.0M+18.7%	$539.0M+18.5%	$455.0M
Operating Income	-$79.0M-41.1%	-$56.0M-243.6%	$39.0M-68.3%	$123.0M-35.9%	$192.0M+220.0%	$60.0M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	-$15.0M-7.1%	-$14.0M	$0-100.0%	$27.0M-34.1%	$41.0M+192.9%	$14.0M
Net Income	-$100.0M+65.5%	-$290.0M-7350.0%	$4.0M-95.7%	$92.0M-38.7%	$150.0M+248.8%	$43.0M
EPS (Diluted)	$-0.59+72.8%	$-2.17-7333.3%	$0.03-96.2%	$0.79-39.2%	$1.30+251.4%	$0.37

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$1.5B+3.4%	$1.4B+0.1%	$1.4B-1.0%	$1.4B-14.0%	$1.7B+60.3%	$1.0B+11.8%	$930.0M+1.9%	$913.0M
Cost of Revenue	$1.2B+5.8%	$1.1B+1.7%	$1.1B-3.0%	$1.2B-15.0%	$1.4B+67.7%	$809.0M+15.6%	$700.0M+0.1%	$699.0M
Gross Profit	$266.0M-6.3%	$284.0M-5.6%	$301.0M+7.5%	$280.0M-9.7%	$310.0M+34.2%	$231.0M+0.4%	$230.0M+7.5%	$214.0M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$200.0M-3.8%	$208.0M-2.8%	$214.0M+1.9%	$210.0M-3.7%	$218.0M+46.3%	$149.0M-3.2%	$154.0M+6.2%	$145.0M
Operating Income	-$42.0M-500.0%	-$7.0M	$0+100.0%	-$30.0M-25.0%	-$24.0M-20.0%	-$20.0M	$0+100.0%	-$12.0M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	-$5.0M-400.0%	-$1.0M0.0%	-$1.0M+87.5%	-$8.0M0.0%	-$8.0M-900.0%	$1.0M+200.0%	-$1.0M+83.3%	-$6.0M
Net Income	-$46.0M-228.6%	-$14.0M-55.6%	-$9.0M+71.0%	-$31.0M-24.0%	-$25.0M+89.7%	-$243.0M-3371.4%	-$7.0M+53.3%	-$15.0M
EPS (Diluted)	N/A	$-0.08-60.0%	$-0.05+72.2%	$-0.18	N/A	$-1.81-2916.7%	$-0.06+53.8%	$-0.13

RXO Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$3.3B-4.0%	$3.4B+87.1%	$1.8B-10.1%	$2.0B-1.8%	$2.1B	N/A
Current Assets	$1.3B-1.6%	$1.3B+68.2%	$796.0M-22.6%	$1.0B-5.0%	$1.1B	N/A
Cash & Equivalents	$17.0M-51.4%	$35.0M+600.0%	$5.0M-94.9%	$98.0M+237.9%	$29.0M-58.6%	$70.0M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$1.2B-0.1%	$1.2B+65.1%	$743.0M-17.4%	$900.0M-10.9%	$1.0B	N/A
Goodwill	$1.1B-1.1%	$1.1B+78.3%	$630.0M0.0%	$630.0M0.0%	$630.0M	N/A
Total Liabilities	$1.7B-3.7%	$1.8B+46.4%	$1.2B-14.8%	$1.4B+44.7%	$998.0M	N/A
Current Liabilities	$1.0B-2.5%	$1.1B+56.2%	$682.0M-17.1%	$823.0M+0.9%	$816.0M	N/A
Long-Term Debt	$387.0M+10.3%	$351.0M-1.4%	$356.0M-21.1%	$451.0M	$0	N/A
Total Equity	$1.5B-4.4%	$1.6B+171.4%	$594.0M+1.2%	$587.0M-45.1%	$1.1B+0.2%	$1.1B
Retained Earnings	-$384.0M-35.2%	-$284.0M-4833.3%	$6.0M+200.0%	$2.0M	$0	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$3.3B+2.4%	$3.2B0.0%	$3.2B-3.1%	$3.3B-3.2%	$3.4B+0.6%	$3.4B+87.1%	$1.8B+0.8%	$1.8B
Current Assets	$1.3B+9.7%	$1.2B+1.4%	$1.2B-5.7%	$1.3B-6.3%	$1.3B+6.7%	$1.3B+61.7%	$776.0M+0.8%	$770.0M
Cash & Equivalents	$17.0M-32.0%	$25.0M+38.9%	$18.0M+12.5%	$16.0M-54.3%	$35.0M-36.4%	$55.0M+685.7%	$7.0M0.0%	$7.0M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$1.2B+11.1%	$1.1B+3.7%	$1.1B-7.4%	$1.1B-6.3%	$1.2B+7.8%	$1.1B+57.0%	$725.0M+1.3%	$716.0M
Goodwill	$1.1B-1.1%	$1.1B-0.2%	$1.1B+0.1%	$1.1B+0.1%	$1.1B+9.3%	$1.0B+63.0%	$630.0M0.0%	$630.0M
Total Liabilities	$1.7B+7.1%	$1.6B+0.5%	$1.6B-6.1%	$1.7B-4.7%	$1.8B+3.6%	$1.7B+41.0%	$1.2B+1.4%	$1.2B
Current Liabilities	$1.0B+14.4%	$907.0M+3.1%	$880.0M-8.7%	$964.0M-9.5%	$1.1B+12.5%	$947.0M+43.1%	$662.0M-1.8%	$674.0M
Long-Term Debt	$387.0M0.0%	$387.0M0.0%	$387.0M0.0%	$387.0M+10.3%	$351.0M-0.3%	$352.0M-4.9%	$370.0M+5.4%	$351.0M
Total Equity	$1.5B-2.5%	$1.6B-0.5%	$1.6B+0.1%	$1.6B-1.6%	$1.6B-2.4%	$1.7B+185.3%	$579.0M-0.5%	$582.0M
Retained Earnings	-$384.0M-13.6%	-$338.0M-4.3%	-$324.0M-2.9%	-$315.0M-10.9%	-$284.0M-9.7%	-$259.0M-1518.8%	-$16.0M-77.8%	-$9.0M

RXO Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$51.0M+525.0%	-$12.0M-113.5%	$89.0M-71.3%	$310.0M+100.0%	$155.0M+520.0%	$25.0M
Capital Expenditures	$59.0M+31.1%	$45.0M-29.7%	$64.0M+12.3%	$57.0M+46.2%	$39.0M-17.0%	$47.0M
Free Cash Flow	-$8.0M+86.0%	-$57.0M-328.0%	$25.0M-90.1%	$253.0M+118.1%	$116.0M+627.3%	-$22.0M
Investing Cash Flow	-$71.0M+93.3%	-$1.1B-1512.1%	-$66.0M-17.9%	-$56.0M-47.4%	-$38.0M+2.6%	-$39.0M
Financing Cash Flow	$1.0M-99.9%	$1.1B+1047.0%	-$117.0M+36.1%	-$183.0M-15.8%	-$158.0M-593.8%	$32.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$0	$0-100.0%	$2.0M	$0	$0	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$7.0M-69.6%	$23.0M0.0%	$23.0M+1250.0%	-$2.0M+71.4%	-$7.0M0.0%	-$7.0M-40.0%	-$5.0M-171.4%	$7.0M
Capital Expenditures	$16.0M+14.3%	$14.0M0.0%	$14.0M-6.7%	$15.0M+25.0%	$12.0M+9.1%	$11.0M0.0%	$11.0M0.0%	$11.0M
Free Cash Flow	-$9.0M-200.0%	$9.0M0.0%	$9.0M+152.9%	-$17.0M+10.5%	-$19.0M-5.6%	-$18.0M-12.5%	-$16.0M-300.0%	-$4.0M
Investing Cash Flow	-$15.0M-15.4%	-$13.0M+27.8%	-$18.0M+28.0%	-$25.0M-108.3%	-$12.0M+98.8%	-$1.0B-9263.6%	-$11.0M0.0%	-$11.0M
Financing Cash Flow	$0+100.0%	-$3.0M0.0%	-$3.0M-142.9%	$7.0M+600.0%	$1.0M-99.9%	$1.1B+6681.3%	$16.0M+166.7%	$6.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	$0	$0	N/A	N/A

RXO Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	19.7%-1.9pp	21.6%-2.8pp	24.4%0.0pp	24.4%+2.9pp	21.5%-2.0pp	23.5%
Operating Margin	-1.4%-0.1pp	-1.2%-2.2pp	1.0%-1.6pp	2.6%-1.5pp	4.1%+2.3pp	1.8%
Net Margin	-1.7%+4.6pp	-6.4%-6.5pp	0.1%-1.8pp	1.9%-1.3pp	3.2%+1.9pp	1.3%
Return on Equity	-6.5%+11.5pp	-18.0%-18.7pp	0.7%-15.0pp	15.7%+1.7pp	14.0%+10.0pp	4.0%
Return on Assets	-3.0%+5.4pp	-8.5%-8.7pp	0.2%-4.3pp	4.5%-2.7pp	7.2%	N/A
Current Ratio	1.27+0.0	1.26+0.1	1.17-0.1	1.25-0.1	1.33	N/A
Debt-to-Equity	0.25+0.0	0.22-0.4	0.60-0.2	0.77+0.8	0.00	N/A
FCF Margin	-0.1%+1.1pp	-1.3%-1.9pp	0.6%-4.6pp	5.3%+2.8pp	2.5%+3.1pp	-0.7%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	18.1%-1.9pp	20.0%-1.2pp	21.2%+1.7pp	19.5%+0.9pp	18.6%-3.6pp	22.2%-2.5pp	24.7%+1.3pp	23.4%
Operating Margin	-2.9%-2.4pp	-0.5%-0.5pp	0.0%+2.1pp	-2.1%-0.6pp	-1.4%+0.5pp	-1.9%-1.9pp	0.0%+1.3pp	-1.3%
Net Margin	-3.1%-2.1pp	-1.0%-0.4pp	-0.6%+1.5pp	-2.2%-0.7pp	-1.5%+21.9pp	-23.4%-22.6pp	-0.8%+0.9pp	-1.6%
Return on Equity	-3.0%-2.1pp	-0.9%-0.3pp	-0.6%+1.4pp	-1.9%-0.4pp	-1.6%+13.2pp	-14.7%-13.5pp	-1.2%+1.4pp	-2.6%
Return on Assets	-1.4%-1.0pp	-0.4%-0.2pp	-0.3%+0.7pp	-0.9%-0.2pp	-0.7%+6.4pp	-7.2%-6.8pp	-0.4%+0.4pp	-0.8%
Current Ratio	1.27-0.1	1.32-0.0	1.35+0.0	1.30+0.0	1.26-0.1	1.33+0.2	1.17+0.0	1.14
Debt-to-Equity	0.250.0	0.240.0	0.240.0	0.24+0.0	0.220.0	0.21-0.4	0.64+0.0	0.60
FCF Margin	-0.6%-1.2pp	0.6%0.0pp	0.6%+1.8pp	-1.2%-0.1pp	-1.1%+0.6pp	-1.7%0.0pp	-1.7%-1.3pp	-0.4%

Similar Companies

Schneider Nation SNDR

$4.6B

Knight-Swift Transn Hldgs Inc KNX

$9.4B

Saia Inc SAIA

$9.5B

Arcbest Corp ARCB

$2.2B

Werner Entprise WERN

$1.8B

Frequently Asked Questions

What is RXO Inc's annual revenue?

RXO Inc (RXO) reported $5.7B in total revenue for fiscal year 2025. This represents a 26.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is RXO Inc's revenue growing?

RXO Inc (RXO) revenue grew by 26.2% year-over-year, from $4.5B to $5.7B in fiscal year 2025.

Is RXO Inc profitable?

No, RXO Inc (RXO) reported a net income of -$100.0M in fiscal year 2025, with a net profit margin of -1.7%.

What is RXO Inc's EBITDA?

RXO Inc (RXO) had EBITDA of $37.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does RXO Inc have?

As of fiscal year 2025, RXO Inc (RXO) had $17.0M in cash and equivalents against $387.0M in long-term debt.

What is RXO Inc's gross margin?

RXO Inc (RXO) had a gross margin of 19.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is RXO Inc's operating margin?

RXO Inc (RXO) had an operating margin of -1.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is RXO Inc's net profit margin?

RXO Inc (RXO) had a net profit margin of -1.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is RXO Inc's return on equity (ROE)?

RXO Inc (RXO) has a return on equity of -6.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is RXO Inc's free cash flow?

RXO Inc (RXO) generated -$8.0M in free cash flow during fiscal year 2025. This represents a 86.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is RXO Inc's operating cash flow?

RXO Inc (RXO) generated $51.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are RXO Inc's total assets?

RXO Inc (RXO) had $3.3B in total assets as of fiscal year 2025, including both current and long-term assets.

What are RXO Inc's capital expenditures?

RXO Inc (RXO) invested $59.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does RXO Inc have outstanding?

RXO Inc (RXO) had 164M shares outstanding as of fiscal year 2025.

What is RXO Inc's current ratio?

RXO Inc (RXO) had a current ratio of 1.27 as of fiscal year 2025, which is considered adequate.

What is RXO Inc's debt-to-equity ratio?

RXO Inc (RXO) had a debt-to-equity ratio of 0.25 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is RXO Inc's return on assets (ROA)?

RXO Inc (RXO) had a return on assets of -3.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is RXO Inc's Piotroski F-Score?

RXO Inc (RXO) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are RXO Inc's earnings high quality?

RXO Inc (RXO) has an earnings quality ratio of -0.51x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is RXO Inc?

RXO Inc (RXO) scores 40 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.